A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

By Popovic‐Todorovic B.  

Human Reproduction, Vol. 18, Iss. 4, 2003-04 ,pp. : 781-787

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon ® ) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP ® ) in a fixed-dose regimen in women undergoing ovarian stimulation

By Hoomans Eric H.M.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2442-2447

Oxford University Press

Access to resources Recommend Favorite

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

By Kilani Z.  

Human Reproduction, Vol. 18, Iss. 6, 2003-06 ,pp. : 1194-1199

Oxford University Press

Access to resources Recommend Favorite

Infertility. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI

By Wikland M.  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1676-1681

Oxford University Press

Access to resources Recommend Favorite

A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles

By Out Henk J.  

Human Reproduction, Vol. 16, Iss. 6, 2001-06 ,pp. : 1104-1109

Oxford University Press

Access to resources Recommend Favorite